glp-1 digital health platforms startups Startups, big players ramp up focus on weight loss drug market Overcoming GLP-1's challenge through innovation
Description
OPTN/SRTR 2021 annual data report: kidney

European Medicines Agency website

Datos oficiales sealan que aproximadamente el 40 % de los adultos en Estados Unidos vive con obesidad, definida por un ndice de masa corporal (IMC) de 30 o ms

Expert Opin Drug Discovery (2015) 10:82539

doi:10.1016/j.regpep.2012.04.006 80
